findmyKOL
Clinical trialNCT07110844RecruitingPhase 2Interventional

Teclistamab-Daratumumab in AL Amyloidosis

SponsorRajshekhar Chakraborty, MDEnrollment25Amyloid Light-chain Amyloidosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to investigate whether teclistamab-daratumumab combination is effective and safe in AL amyloidosis. The study treatment is divided into cycles (C) and each cycle is 28 days (D). Study treatment is expected to last 6 months.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Boston Medical Center

    Boston, Massachusetts, United States

    Not, yet, recruiting
  • Columbia University Irving Medical Center

    New York, New York, United States

    Rajshekhar Chakraborty, MD
    Recruiting
  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

    Anita D'Souza, MD, MS
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Daratumumab and Hyaluronidase-fihjTeclistamab →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Nov 2025
Primary completion
31 Oct 2031
Completion
31 Oct 2033
Last update posted
13 Jul 2026
Registered enrollment
25
Registry id
NCT07110844
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.